2025 ICD-10-CM Diagnosis Code C80.2

by

Malignant neoplasm associated with transplanted organ

  • C80.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2025 edition of ICD-10-CM C80.2 became effective on October 1, 2024.
  • This is the American ICD-10-CM version of C80.2 – other international versions of ICD-10 C80.2 may differ.

Use Additional

  • code to identify the specific malignancy

Code First

  • complication of transplanted organ (T86.-)

The following code(s) above C80.2 contain annotation back-references

 that may be applicable to C80.2:

  • C00-D49  Neoplasms
  • C80  Malignant neoplasm without specification of site

Approximate Synonyms

  • Malignant neoplasm associated w transplant organ
  • Malignant neoplasm associated with kidney transplant
  • Malignant neoplasm associated with transplant
  • Malignant neoplasm with bone marrow transplant
  • Malignant neoplasm with liver transplant
  • Malignant neoplasm with lung transplant
  • Post bone marrow transplant neoplasia
  • Post heart transplant neoplasia
  • Post intestinal transplant neoplasia
  • Post kidney transplant neoplasia
  • Post liver transplant neoplasia
  • Post lung transplant neoplasia
  • Post organ-transplant malignant neoplasia
  • Post pancreas transplant neoplasia
  • Post-transplant neoplasia

ICD-10-CM C80.2 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):

  • 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
  • 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
  • 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
  • 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
  • 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
  • 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
  • 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
  • 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Convert C80.2 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
  • 2025 (effective 10/1/2024): No change

Code annotations containing back-references to C80.2:

  • Use Additional: T86

Diagnosis Index entries containing back-references to C80.2:

error: Content is protected !!